Market Opportunity Reports

Market Scope uses a multi-source methodology when preparing our annual and quarterly reports. We incorporate surgeon surveys, our extensive database of physicians and surgery centers, disease models, clinical studies, financial reports, and more. Our wide-ranging knowledge of products and technology and our comprehensive network of industry contacts also contribute to our coverage on the ophthalmic industry.

2024 United States Cataract Atlas Featuring the Market Scope Exclusive MedOp Index™ Analysis, April, 2024

COMING
SOON

2024 United States Cataract Atlas Featuring the Market Scope Exclusive MedOp Index™ Analysis, April, 2024

2024 United States Refractive Atlas Featuring the Market Scope Exclusive MedOp Index™ Analysis, March, 2024

The “2024 United States Refractive Atlas” provides a geographic analysis of the US refractive market in 85 metropolitan areas. Market Scope’s MedOp Index™ Analysis is used to identify the potential for refractive surgery and considers many factors for each geography, including:  population age distribution, refractive error, income/buying power, overall health, education level, and location of refractive surgeons and LVC centers. High-opportunity populations and benchmarking comparisons are provided for each metropolitan area. Additionally, the atlas provides a comprehensive directory of all US practices offering refractive surgery. Market Scope also offers customization of atlas data to align with sales territories or specific geographic areas.

2023 United States Retina Atlas Featuring the Market Scope Exclusive MedOp Index™ Analysis, June, 2023

The “2023 United States Retina Atlas” provides a geographic analysis of retinal treatment opportunity and key demographic metrics in 85 US metropolitan areas. Market Scope’s proprietary MedOp Index™ Analysis examines market potential and provides a benchmark against other metros. The Retina Atlas offers strategic insights into the top potential markets in the US by providing:

  • Demographic information of selected metropolitan populations
  • Profiles of selected metropolitan areas and applicable retinal treatment opportunity
  • Current estimates for retinal surgery volume by metropolitan area
  • Current estimates for retina surgeons by metropolitan area
  • Comprehensive directory of US ophthalmic practices performing retinal IVTs and vitrectomies

2022 United States Glaucoma Atlas Featuring the Market Scope Exclusive MedOp Index™ Analysis, May, 2022

The “2022 United States Glaucoma Atlas” provides a geographic analysis of the glaucoma population and treatment opportunity in 85 US metropolitan areas. Market Scope’s proprietary MedOp Index Analysis™ analyzes market potential and provides a benchmark against other atlas metros. The atlas offers strategic insights into the top potential markets in the US, which companies often use throughout the development and commercialization processes to identify ideal clinical trial locations, develop launch strategies, define sales territories, allocate resources, and optimize sales and marketing initiatives.

Want to Purchase the Full Report?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more